Dr. Michael Brad Cearlock, MD

Dr. Cearlock practices at Marshfield Medical Center - Marshfield in Marshfield, Wisconsin, part of Sanford Health.

Dr. Cearlock's NPI, 1053577908, was assigned on July 30, 2008. Dr. Cearlock holds Michigan license 4301097632.

Dr. Cearlock's primary practice is Marshfield Medical Center - Marshfield, at 611 St Joseph Ave, Marshfield, WI 54449 in Wood County. The practice phone is (715) 387-9963.

Dr. Cearlock's primary practice is Marshfield Medical Center - Marshfield in Marshfield, Wisconsin, part of Sanford Health. Dr. Cearlock is also affiliated with Marshfield Medical Center - Rice Lake. The medical group on file is Marshfield Clinic Health System. Dmand AI also links Dr. Cearlock to 3 more hospitals and 6 medical groups, each named with a free account. Dr. Cearlock's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cearlock practices, 5 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Cearlock's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dmand AI has Dr. Cearlock's licenses on file in 2 states: Michigan and Wisconsin.

CMS data shows 85 Medicare services from Dr. Cearlock across 4 procedure codes in 2024, for 99 Medicare patients. Medicare paid $7,192 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 99 Medicare patients who saw Dr. Cearlock in 2024. The largest group is 75 to 84, with 33 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 40% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cearlock's median patient age at 54, with 55% women.

In 2024, Dr. Cearlock wrote 251 Medicare Part D claims for 161 patients. 94% of them were for generic drugs. CMS names the drug for 112 of them, across 6 drugs with 11 or more claims each, at $598 in total drug cost. In 2023, CMS named 192 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Cearlock for performance year 2024, reported as part of a group. Dr. Cearlock accepts Medicare assignment, so Medicare's approved amount is taken as full payment.